logo
  

McDonald's To Close Majority Of Outlets At Walmart: WSJ

Fast-food giant MacDonald's Corporation (MCD) will close hundreds of outlets inside Walmart Inc.'s stores (WMT) across the country, reported Wall Street Journal on Friday.

McDonald's have slowly reduced the number of outlets inside malls through the year and the lack of footfall during the pandemic has only sped up the process.

According to McDonald's CFO Kevin Ozan, "The U.S. is accelerating some restaurant closures previously planned for future years. Of the 200 U.S. closures for this year, over half are low-volume restaurants in Walmart store locations".

It is understood that only 150 outlets will remain across 3,570 Walmart SuperCenters. "Markets with a higher percentage of drive-thrus are showing quicker recovery. Markets with a higher concentration of city center and mall restaurants are seeing a heavier impact from reduced foot traffic." added Ozan.

The two companies have been in this symbiotic relationship for more than three decades but the pandemic has changed the scenario. Walmart's e-commerce platform has reported a 79% growth in the last financial year. Since fewer people are turning up to shop at Walmart, and more people are opting for deliveries and drive-throughs at McDonald's, the decision came as inevitable.

McDonald's is operating in 13,835 locations at the moment, a 3.5% drop from 14,350 locations in 2014.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Southwest Airlines' flights across the United States were delayed for hours on Monday evening due to technical issue in a weather information system by a third-party weather data provider. The airline later resumed flight operations after solving the issue, but there were delays. The United Kingdom's Competition and Markets Authority or CMA announced Tuesday that it has launched a market study into mobile ecosystems of technology giants Apple Inc. (AAPL) and Google, Inc. (GOOG) over concerns they have market power which is harming users and other businesses. The CMA is taking... Eli Lilly and Co. (LLY) announced Tuesday that it will conduct a head-to-head study comparing once-monthly injectable Emgality (galcanezumab-gnlm) with Nurtec ODT (rimegepant), an orally disintegrating tablet patients take every other day. This study will help to advance the science of migraine treatment...
Follow RTT